Published 6 issues per year
ISSN Print: 1040-8401
ISSN Online: 2162-6472
Indexed in
Function of Histone Deacetylase Inhibitors in Inflammation
ABSTRACT
Histone deacetylases (HDACs) display multi-faceted roles in coordinating the interaction of intracellular signaling pathways with chromatin remodeling and transcription factor function to finely specify gene alterations and maintenance of gene expression during cellular activation, proliferation, and differentiation. These processes, epigenetic and non-epigenetic, are critical to the development of both the adaptive and innate arms of the mammalian immune system, and the measured initiation and resolution of immune responses. Pharmacological modulators of HDAC activity have demonstrated uniformly potent anti-inflammatory effects in experimental animal models of these diseases, in relevant immune and stromal cell populations from patients, as well as initial successes in the clinic. Recent studies have identified key roles for specific HDACs in regulating immune function, as well as alterations in HDAC expression and function in a number of immune-mediated inflammatory diseases (IMIDs), which may contribute to pathology in these diseases. Here, we review recent advances in our understanding of HDAC function in the immune system, their contribution to IMIDs, and the therapeutic potential of altering HDAC activity in IMIDs.
-
Ziesché Elisabeth, Kettner-Buhrow Daniela, Weber Axel, Wittwer Tobias, Jurida Liane, Soelch Johanna, Müller Helmut, Newel Doris, Kronich Petra, Schneider Heike, Dittrich-Breiholz Oliver, Bhaskara Srividya, Hiebert Scott W., Hottiger Michael O., Li Haiying, Burstein Ezra, Schmitz M. Lienhard, Kracht Michael, The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB, Nucleic Acids Research, 41, 1, 2013. Crossref
-
Qu Yiqing, Yang Yie, Ma Dedong, He Liangai, Xiao Wei, Expression level of histone deacetylase 2 correlates with occurring of chronic obstructive pulmonary diseases, Molecular Biology Reports, 40, 6, 2013. Crossref
-
Zhang Xin, Han Shu, Kang Yindong, Guo Meng, Hong Shanjuan, Liu Fang, Fu Shangxi, Wang Liming, Wang Quan-Xing, SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection, Cellular & Molecular Immunology, 9, 5, 2012. Crossref
-
Grabiec Aleksander M., Reedquist Kris A., The ascent of acetylation in the epigenetics of rheumatoid arthritis, Nature Reviews Rheumatology, 9, 5, 2013. Crossref
-
Zhang Xin, Guo Meng, Kang Yindong, Liu Fang, Zheng Xueyang, Han Shu, Fu Shangxi, Hong Shanjuan, Ding Guoshan, Wang Liming, Wang Quan-xing, SAHA, an HDAC Inhibitor, Attenuates Antibody-Mediated Allograft Rejection, Transplantation, 96, 6, 2013. Crossref
-
Rasmussen Thomas Aagaard, Søgaard Ole Schmeltz, Brinkmann Christel, Wightman Fiona, Lewin Sharon R., Melchjorsen Jesper, Dinarello Charles, Østergaard Lars, Tolstrup Martin, Comparison of HDAC inhibitors in clinical development, Human Vaccines & Immunotherapeutics, 9, 5, 2013. Crossref
-
Dekker Frank J., van den Bosch Thea, Martin Nathaniel I., Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases, Drug Discovery Today, 19, 5, 2014. Crossref
-
Gray Steven G, Perspectives on epigenetic-based immune intervention for rheumatic diseases, Arthritis Research & Therapy, 15, 2, 2013. Crossref
-
Sun Yaping, Reddy Pavan, Intracellular sensors of immunity and allogeneic hematopoietic stem cell transplantation, in Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation, 2013. Crossref
-
Ahmed Salahuddin, Riegsecker Sharayah, Beamer Maria, Rahman Ayesha, Bellini Joseph V., Bhansali Pravin, Tillekeratne L.M. Viranga, Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts, Toxicology and Applied Pharmacology, 270, 2, 2013. Crossref
-
Diao Jian-Sheng, Xia Wen-Sen, Yi Cheng-Gang, Yang Yang, Zhang Xi, Xia Wei, Shu Mao-Guo, Wang Ying-Mei, Gui Lin, Guo Shu-Zhong, Histone Deacetylase Inhibitor Reduces Hypertrophic Scarring in a Rabbit Ear Model, Plastic and Reconstructive Surgery, 132, 1, 2013. Crossref
-
Kong Sinyi, Yeung Pricilla, Fang Deyu, The Class III Histone Deacetylase Sirtuin 1 in Immune Suppression and Its Therapeutic Potential in Rheumatoid Arthritis, Journal of Genetics and Genomics, 40, 7, 2013. Crossref
-
Rizzo Lucas Bortolotto, Costa Leonardo Gazzi, Mansur Rodrigo B., Swardfager Walter, Belangero Síntia Iole, Grassi-Oliveira Rodrigo, McIntyre Roger S., Bauer Moisés E., Brietzke Elisa, The theory of bipolar disorder as an illness of accelerated aging: Implications for clinical care and research, Neuroscience & Biobehavioral Reviews, 42, 2014. Crossref
-
Miao Cheng-gui, Yang Ying-ying, He Xu, Li Jun, New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2, Cellular Signalling, 25, 4, 2013. Crossref
-
Gómez-Gallego Carlos, Frias Rafael, Pérez-Martínez Gaspar, Bernal María José, Periago María Jesús, Salminen Seppo, Ros Gaspar, Collado María Carmen, Polyamine supplementation in infant formula: Influence on lymphocyte populations and immune system-related gene expression in a Balb/cOlaHsd mouse model, Food Research International, 59, 2014. Crossref
-
Hirabara Sandro M., Gorjão Renata, Vinolo Marco A., Rodrigues Alice C., Nachbar Renato T., Curi Rui, Molecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions, Journal of Biomedicine and Biotechnology, 2012, 2012. Crossref
-
Litvinova L. S., Kirienkova E. V., Mazunin I. O., Vasilenko M. A., Fattakhov N. S., Pathogenesis of insulin resistance in metabolic obesity, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 8, 3, 2014. Crossref
-
Gabrielli Brian, Brown Mellissa, Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint By Targeting Histone and Nonhistone Proteins, in Histone Deacetylase Inhibitors as Cancer Therapeutics, 116, 2012. Crossref
-
Neele Annette E., Van den Bossche Jan, Hoeksema Marten A., de Winther Menno P.J., Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis, European Journal of Pharmacology, 763, 2015. Crossref
-
Ozer Ahmet, Altuntas Cengiz Z., Bicer Fuat, Izgi Kenan, Hultgren Scott J., Liu Guiming, Daneshgari Firouz, Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice, Pathogens and Disease, 73, 3, 2015. Crossref
-
Schaue Dörthe, McBride William H., Opportunities and challenges of radiotherapy for treating cancer, Nature Reviews Clinical Oncology, 12, 9, 2015. Crossref
-
Chen Hui-Min, Chedin Frederic L., Chang Christopher, Leung Patrick S.C., Targeting Epigenetics in the Development of New Diagnostic Applications—Lessons from Autoimmune Diseases, in Epigenetics and Dermatology, 2015. Crossref
-
Akimova Tatiana, Beier Ulf H., Liu Yujie, Wang Liqing, Hancock Wayne W., Histone/protein deacetylases and T-cell immune responses, Blood, 119, 11, 2012. Crossref
-
Leggatt Graham R, Gabrielli Brian, Histone deacetylase inhibitors in the generation of the anti‐tumour immune response, Immunology & Cell Biology, 90, 1, 2012. Crossref
-
Schölz Christian, Weinert Brian T, Wagner Sebastian A, Beli Petra, Miyake Yasuyuki, Qi Jun, Jensen Lars J, Streicher Werner, McCarthy Anna R, Westwood Nicholas J, Lain Sonia, Cox Jürgen, Matthias Patrick, Mann Matthias, Bradner James E, Choudhary Chunaram, Acetylation site specificities of lysine deacetylase inhibitors in human cells, Nature Biotechnology, 33, 4, 2015. Crossref
-
Toussirot Eric, Abbas Wasim, Khan Kashif Aziz, Tissot Marion, Jeudy Alicia, Baud Lucile, Bertolini Ewa, Wendling Daniel, Herbein Georges, Bobe Pierre, Imbalance between HAT and HDAC Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of HDAC Inhibitors on TNF Alpha Production, PLoS ONE, 8, 8, 2013. Crossref
-
van den Bosch Thea, Leus Niek G.J., Timmerman Tirza, Dekker Frank J., Small Molecule Inhibitors of Histone Deacetylases and Acetyltransferases as Potential Therapeutics in Oncology, in Drug Discovery in Cancer Epigenetics, 2016. Crossref
-
Tzeng Thing-Fong, Liu Wayne, Liou Shorong-Shii, Hong Tang-Yao, Liu I-Min, Antioxidant-Rich Extract from Plantaginis Semen Ameliorates Diabetic Retinal Injury in a Streptozotocin-Induced Diabetic Rat Model, Nutrients, 8, 9, 2016. Crossref
-
Angiolilli Chiara, Grabiec Aleksander M, Ferguson Bradley S, Ospelt Caroline, Malvar Fernandez Beatriz, van Es Inge E, van Baarsen Lisa G M, Gay Steffen, McKinsey Timothy A, Tak Paul P, Baeten Dominique L, Reedquist Kris A, Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression, Annals of the Rheumatic Diseases, 75, 2, 2016. Crossref
-
Leus Niek GJ, Zwinderman Martijn RH, Dekker Frank J, Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation, Current Opinion in Chemical Biology, 33, 2016. Crossref
-
D’Urzo Annalisa, Boichenko Alexander P., van den Bosch Thea, Hermans Jos, Dekker Frank, Andrisano Vincenza, Bischoff Rainer, Site-specific quantification of lysine acetylation in the N-terminal tail of histone H4 using a double-labelling, targeted UHPLC MS/MS approach, Analytical and Bioanalytical Chemistry, 408, 13, 2016. Crossref
-
Altorok N., Nada S., Nagaraja V., Kahaleh B., Epigenetics in Bone and Joint Disorders, in Medical Epigenetics, 2016. Crossref
-
Grabiec Aleksander M., Potempa Jan, Epigenetic regulation in bacterial infections: targeting histone deacetylases, Critical Reviews in Microbiology, 44, 3, 2018. Crossref
-
Edwards CJ, Costenbader KH, Epigenetics and the microbiome: developing areas in the understanding of the aetiology of lupus, Lupus, 23, 6, 2014. Crossref
-
Morinobu Akio, Tanaka Shino, Nishimura Keisuke, Takahashi Soshi, Kageyama Goichi, Miura Yasushi, Kurosaka Masahiro, Saegusa Jun, Kumagai Shunichi, Kuwana Masataka, Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts, PLOS ONE, 11, 10, 2016. Crossref
-
Lima Francisco Arnaldo Viana, Joventino Ivan Pinheiro, Joventino Francisca Pinheiro, de Almeida Aline Cordeiro, Neves Kelly Rose Tavares, do Carmo Marta Regina, Leal Luzia Kalyne Almeida Moreira, de Andrade Geanne Matos, de Barros Viana Glauce Socorro, Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson’s Disease Are Related to Its Anti-Inflammatory Effects, Neurochemical Research, 42, 12, 2017. Crossref
-
Dayoub Ousama, Le Lay Soazig, Soleti Raffaella, Clere Nicolas, Hilairet Gregory, Dubois Séverine, Gagnadoux Frédéric, Boursier Jérôme, Martínez Maria Carmen, Andriantsitohaina Ramaroson, Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks, Scientific Reports, 7, 1, 2017. Crossref
-
Zeb Amir, Park Chanin, Son Minky, Rampogu Shailima, Alam Syed Ibrar, Park Seok Ju, Lee Keun Woo, Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach, Journal of Bioinformatics and Computational Biology, 16, 03, 2018. Crossref
-
Zhao Yingbo, Wu Tianjian, Histone deacetylase inhibition inhibits brachial plexus avulsion-induced neuropathic pain, Muscle & Nerve, 58, 3, 2018. Crossref
-
Lkhagva Baigalmaa, Kao Yu-Hsun, Lee Ting-I, Lee Ting-Wei, Cheng Wan-Li, Chen Yi-Jen, Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities, Epigenetics, 13, 4, 2018. Crossref
-
Silva Monalisa Ribeiro, Correia Alyne Oliveira, dos Santos Gabriel Cabral Alencar, Parente Lucas Leimig Telles, de Siqueira Keicy Parente, Lima Danielly Gonçalves Sombra, Moura Jonathan Almeida, da Silva Ribeiro Ana Elisa, Costa Roberta Oliveira, Lucetti Daniel Luna, Lucetti Elaine Cristina Pereira, Neves Kelly Rose Tavares, de Barros Viana Glauce Socorro, Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions, Pharmacology Biochemistry and Behavior, 167, 2018. Crossref
-
Delgado Félix, Cárdenas Paola, Castellanos Jaime, Valproic Acid Downregulates Cytokine Expression in Human Macrophages Infected with Dengue Virus, Diseases, 6, 3, 2018. Crossref
-
de-Almeida S.C.X., da-Silva Â.C.F., Sousa N.R.T., Amorim I.H.F., Leite B.G., Neves K.R.T., Costa J.G.M., Felipe C.F.B., de-Barros Viana G.S., Antinociceptive and anti-inflammatory activities of a triterpene-rich fraction from Himatanthus drasticus, Brazilian Journal of Medical and Biological Research, 52, 5, 2019. Crossref
-
Zhang Xian, Shi En, Yang Lan, Fu Weina, Hu Feng, Zhou Xisong, Gentiopicroside attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress, and NF-κB activation in rat model, European Journal of Inflammation, 17, 2019. Crossref
-
Byersdorfer Craig, Reddy Pavan, Intracellular Sensors and Cellular Metabolism in Allogeneic Hematopoietic Stem Cell Transplantation, in Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation, 2019. Crossref
-
Lagosz K.B., Bysiek A., Macina J.M., Bereta G.P., Kantorowicz M., Lipska W., Sochalska M., Gawron K., Kaczmarzyk T., Chomyszyn-Gajewska M., Fossati G., Potempa J., Grabiec A.M., HDAC3 Regulates Gingival Fibroblast Inflammatory Responses in Periodontitis, Journal of Dental Research, 99, 1, 2020. Crossref
-
Castro-Santos P., Díaz-Peña R., Pharmacoepigenetics of Rheumatic Disorders, in Pharmacoepigenetics, 2019. Crossref
-
Nijhuis Lotte, Peeters Janneke G. C., Vastert Sebastiaan J., van Loosdregt Jorg, Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis, Frontiers in Immunology, 10, 2019. Crossref
-
Maksylewicz Anna, Bysiek Agnieszka, Lagosz Katarzyna B., Macina Justyna M., Kantorowicz Malgorzata, Bereta Grzegorz, Sochalska Maja, Gawron Katarzyna, Chomyszyn-Gajewska Maria, Potempa Jan, Grabiec Aleksander M., BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients, Frontiers in Immunology, 10, 2019. Crossref
-
Litvinova L.S., Kirienkova E.V., Mazunin I.O., Vasilenko M.A., Fattakhov N.S., Insulin resistance pathogenesis in metabolic obesity, Biomeditsinskaya Khimiya, 61, 1, 2015. Crossref
-
Molstad David H. H., Zars Elizabeth, Norton Andrew, Mansky Kim C., Westendorf Jennifer J., Bradley Elizabeth W., Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1, Scientific Reports, 10, 1, 2020. Crossref
-
Jurdziński Krzysztof T., Potempa Jan, Grabiec Aleksander M., Epigenetic regulation of inflammation in periodontitis: cellular mechanisms and therapeutic potential, Clinical Epigenetics, 12, 1, 2020. Crossref
-
Lagosz Katarzyna B., Grabiec Aleksander M., Targeting histone deacetylases for bacterial infections, in Histone Modifications in Therapy, 2020. Crossref
-
Librizzi Mariangela, Longo Alessandra, Chiarelli Roberto, Amin Jahanghir, Spencer John, Luparello Claudio, Cytotoxic Effects of Jay Amin Hydroxamic Acid (JAHA), a Ferrocene-Based Class I Histone Deacetylase Inhibitor, on Triple-Negative MDA-MB231 Breast Cancer Cells, Chemical Research in Toxicology, 25, 11, 2012. Crossref
-
van den Bosch Thea, Kwiatkowski Marcel, Bischoff Rainer, Dekker Frank J, Targeting transcription factor lysine acetylation in inflammatory airway diseases, Epigenomics, 9, 7, 2017. Crossref
-
Bürli Roland W., Luckhurst Christopher A., Aziz Omar, Matthews Kim L., Yates Dawn, Lyons Kathy. A., Beconi Maria, McAllister George, Breccia Perla, Stott Andrew J., Penrose Stephen D., Wall Michael, Lamers Marieke, Leonard Philip, Müller Ilka, Richardson Christine M., Jarvis Rebecca, Stones Liz, Hughes Samantha, Wishart Grant, Haughan Alan F., O’Connell Catherine, Mead Tania, McNeil Hannah, Vann Julie, Mangette John, Maillard Michel, Beaumont Vahri, Munoz-Sanjuan Ignacio, Dominguez Celia, Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease, Journal of Medicinal Chemistry, 56, 24, 2013. Crossref
-
Leonidova Anna, Mari Cristina, Aebersold Christine, Gasser Gilles, Selective Photorelease of an Organometallic-Containing Enzyme Inhibitor, Organometallics, 35, 6, 2016. Crossref
-
Rangwala Sophia, Zhang Chunlei, Duvic Madeleine, HDAC inhibitors for the treatment of cutaneous T-cell lymphomas, Future Medicinal Chemistry, 4, 4, 2012. Crossref
-
Gray Steven G, Epigenetic-based immune intervention for rheumatic diseases, Epigenomics, 6, 2, 2014. Crossref
-
Bouchecareilh Marion, Hutt Darren M., Szajner Patricia, Flotte Terence R., Balch William E., Histone Deacetylase Inhibitor (HDACi) Suberoylanilide Hydroxamic Acid (SAHA)-mediated Correction of α1-Antitrypsin Deficiency, Journal of Biological Chemistry, 287, 45, 2012. Crossref
-
Xu Yang, Wang Yameng, Wang Lulu, Liang Wenxing, Yang Qianqian, Sodium Valproate Is Effective Against Botrytis cinerea Infection of Tomato by Enhancing Histone H3 Acetylation-Directed Gene Transcription and Triggering Tomato Fruit Immune Response, Phytopathology®, 112, 6, 2022. Crossref
-
Schioppa Tiziana, Nguyen Hoang Oanh, Tiberio Laura, Sozio Francesca, Gaudenzi Carolina, Passari Mauro, Del Prete Annalisa, Bosisio Daniela, Salvi Valentina, Inhibition of Class I Histone Deacetylase Activity Blocks the Induction of TNFAIP3 Both Directly and Indirectly via the Suppression of Endogenous TNF-α, International Journal of Molecular Sciences, 23, 17, 2022. Crossref
-
Hong Kyung Euy, Park Hae-Young Lopilly, Kim Jin Woo, Kim Jie Hyun, Park Chan Kee, Global Histone Modifications Predict the Outcome of Glaucoma Surgery, Journal of the Korean Glaucoma Society, 11, 2, 2022. Crossref